Last week, readers were most interested in a story about a possible sale of Siemens Healthineer's IVD business, leading to an uptick in the company's share price.

The program is intended to advance the development of antigen tests that can be used in homes and at the point-of-care to aid the detection of dangerous infections.

Under the agreement, Tempus and Renalytix will work with US healthcare systems to make the KidneyintelX.dkd test more available to order within existing clinical workflows.

Titled the RESULTS Act, the bill would use third-party private-payor data to set Medicare lab payment rates, addressing a ...

Compared to the firm's previous PGx offering, the new service is somewhat smaller in terms of content and better supported by ...

The scientists said that the test could help clinicians overcome a lack of specificity in prostate-specific antigen tests and ...

Auditors said that independent diagnostic labs should be subject to emergency planning rules similar to those already required for various other healthcare providers.

The US Food and Drug Administration issued marketing clearances for antimicrobial susceptibility tests, respiratory infection tests, and a cardiac troponin test, among others.

The Canadian company is also working to increase utilization of its point-of-care infectious disease assays, such as tests for HIV and syphilis.

The firm acquired intellectual property from Mammoth Biosciences that will reduce the speed and cost of its in-development point-of-care solution.

The study will use the BioFire SpotFire system in its assessment of a direct-acting antiviral medicine to treat rhinovirus in patients with COPD.